Rubenstein JH - Search Results

1

AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.

Rubenstein JH, Sawas T, Wani S, Eluri S, Singh S, Chandar AK, Perumpail RB, Inadomi JM, Thrift AP, Piscoya A, Sultan S, Singh S, Katzka D, Davitkov P. Rubenstein JH, et al. Gastroenterology. 2024 Jun;166(6):1020-1055. doi: 10.1053/j.gastro.2024.03.019. Gastroenterology. 2024. PMID: 38763697 Free PMC article.

2

Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable?

Rubenstein JH, Inadomi JM. Rubenstein JH, et al. Hepatology. 2003 Feb;37(2):249-52. doi: 10.1053/jhep.2003.50089. Hepatology. 2003. PMID: 12540773 Free article. Review. No abstract available.

3

A cost-utility analysis of secondary prophylaxis for variceal hemorrhage.

Rubenstein JH, Eisen GM, Inadomi JM. Rubenstein JH, et al. Am J Gastroenterol. 2004 Jul;99(7):1274-88. doi: 10.1111/j.1572-0241.2004.04153.x. Am J Gastroenterol. 2004. PMID: 15233665 Free article.

4

Dysphagia drives doctors to diagnose a disease: pitfalls in interpreting observational studies.

Rubenstein JH, Inadomi JM. Rubenstein JH, et al. Gastrointest Endosc. 2005 Jun;61(7):809-11. doi: 10.1016/s0016-5107(05)00544-4. Gastrointest Endosc. 2005. PMID: 15933680 No abstract available.

5

The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma.

Rubenstein JH, Vakil N, Inadomi JM. Rubenstein JH, et al. Aliment Pharmacol Ther. 2005 Jul 15;22(2):135-46. doi: 10.1111/j.1365-2036.2005.02536.x. Aliment Pharmacol Ther. 2005. PMID: 16011672

6

Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia.

Rubenstein JH, Davis J, Marrero JA, Inadomi JM. Rubenstein JH, et al. Aliment Pharmacol Ther. 2005 Aug 1;22(3):267-71. doi: 10.1111/j.1365-2036.2005.02544.x. Aliment Pharmacol Ther. 2005. PMID: 16091065

7

Defining a clinically significant adverse impact of diagnosing Barrett's esophagus.

Rubenstein JH, Inadomi JM. Rubenstein JH, et al. J Clin Gastroenterol. 2006 Feb;40(2):109-15. doi: 10.1097/01.mcg.0000196186.19426.4a. J Clin Gastroenterol. 2006. PMID: 16394870

8

Evidence based medicine (EBM) in practice: applying results of cost-effectiveness analyses.

Rubenstein JH, Inadomi JM. Rubenstein JH, et al. Am J Gastroenterol. 2006 Jun;101(6):1169-71. doi: 10.1111/j.1572-0241.2006.00452.x. Am J Gastroenterol. 2006. PMID: 16771930 No abstract available.

9

Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.

Rubenstein JH, Inadomi JM, Brill JV, Eisen GM. Rubenstein JH, et al. Clin Gastroenterol Hepatol. 2007 Mar;5(3):312-8. doi: 10.1016/j.cgh.2006.12.008. Clin Gastroenterol Hepatol. 2007. PMID: 17368230

10

Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome.

Rubenstein JH, Nojkov B, Korsnes S, Adlis SA, Shaw MJ, Weinman B, Inadomi JM, Saad R, Chey WD. Rubenstein JH, et al. Aliment Pharmacol Ther. 2007 Aug 1;26(3):443-52. doi: 10.1111/j.1365-2036.2007.03393.x. Aliment Pharmacol Ther. 2007. PMID: 17635379 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters